- Home
- EDSA vs STRR Comparison
EDSA vs STRR Comparison
Compare EDSA & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- STRR
- Stock Information
- Founded
- EDSA 2015
- STRR 1985
- Country
- EDSA Canada
- STRR United States
- Employees
- EDSA N/A
- STRR N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EDSA Health Care
- STRR Health Care
- Exchange
- EDSA Nasdaq
- STRR Nasdaq
- Market Cap
- EDSA 6.2M
- STRR 6.3M
- IPO Year
- EDSA N/A
- STRR N/A
- Fundamental
- Price
- EDSA $1.83
- STRR $2.13
- Analyst Decision
- EDSA Strong Buy
- STRR Strong Buy
- Analyst Count
- EDSA 1
- STRR 1
- Target Price
- EDSA $21.00
- STRR $5.00
- AVG Volume (30 Days)
- EDSA 35.8K
- STRR 61.6K
- Earning Date
- EDSA 05-14-2025
- STRR 05-14-2025
- Dividend Yield
- EDSA N/A
- STRR N/A
- EPS Growth
- EDSA N/A
- STRR N/A
- EPS
- EDSA N/A
- STRR N/A
- Revenue
- EDSA N/A
- STRR $57,165,000.00
- Revenue This Year
- EDSA N/A
- STRR $33.64
- Revenue Next Year
- EDSA N/A
- STRR $22.87
- P/E Ratio
- EDSA N/A
- STRR N/A
- Revenue Growth
- EDSA N/A
- STRR 34.33
- 52 Week Low
- EDSA $1.55
- STRR $1.72
- 52 Week High
- EDSA $5.59
- STRR $5.35
- Technical
- Relative Strength Index (RSI)
- EDSA 29.28
- STRR 47.17
- Support Level
- EDSA $1.88
- STRR $2.16
- Resistance Level
- EDSA $2.05
- STRR $2.75
- Average True Range (ATR)
- EDSA 0.08
- STRR 0.24
- MACD
- EDSA -0.00
- STRR -0.00
- Stochastic Oscillator
- EDSA 0.00
- STRR 32.80
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.